Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-23T04:08:22.224Z Has data issue: false hasContentIssue false

Fluoxetine–terfenadine and sexual dysfunction

Published online by Cambridge University Press:  03 January 2018

A. Valmana
Affiliation:
Department of Psychiatry, St George's Hospital Medical School, Cranmer Terrace, London SWI7 0RE
P. Purcell
Affiliation:
Haleacre Unit, Amersham Hospital, Whielden Street, Amersham, Bucks HP7 0JD
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Copyright
Copyright © 1998 The Royal College of Psychiatrists 

References

Alzenberg, D., Zamishlany, Z. & Weizman, A. (1995) Cyproheptadine treatment of sexual dysfunction induced by SSRI. Clinical Neuropharmacology, 18, 320324.CrossRefGoogle Scholar
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). Washington, DC: APA.Google Scholar
Labatte, L. A. & Pollack, M. H. (1994) Treatment of fluoxetine induced sexual dysfunction with bupropion: a case report. Annals of Clinical Psychiatry, 6, 1315.CrossRefGoogle Scholar
Marchiando, R. J., Cook, M. D. & Jue, S. G. (1995) Probable terfenadine–fluoxetine associated cardiac toxicity (letter). Annals of Pharmacotherapy, 29, 937938.CrossRefGoogle Scholar
Nemeroff, C. B., DaVane, C. L. & Pollock, B. G. (1996) Newer antidepressants and the cytochrome P450 system. American Journal of Psychiatry, 153, 311320.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.